“…Previously, withaferin A-mediated reactive oxygen species (ROS) initiation was noticed in MCF-7 and MDA-MB-231 cell lines that inhibited the effect of withaferin A on cell death, ER-related proteins, paraptotic vacuole formation, X-box-binding protein-1, and mRNA splicing [ 85 ]. In another research, withaferin A suppressed cell proliferation in prostate, ovarian, breast, gastric, leukemic, and melanoma cancer cells and osteosarcomas by stimulating the inhibition of the cell cycle at several stages, including G0/G1 [ 86 ], G2, and M phase [ 87 , 88 , 89 , 90 , 91 ].…”